Join
Live feed
·
INSIDERFilingvia Quantisnow
Precision BioSciences Inc. logo

Director Buehler Kevin bought $21,116 worth of shares (5,076 units at $4.16), increasing direct ownership by 22% to 28,137 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DTIL· Precision BioSciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DTIL (Precision BioSciences Inc.) and more on Quantisnow.